In fact, in the test case, the examination using ovarian clear cell carcinoma cell lines, which are likely to be chemotherapy-resistant, showed a synergistic effect of inhibiting glutamine metabolism and the FAK pathway [24]. Here, PTK2 is linked to ovarian clear cell cancer.